Cited by 36Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsHeparin-Induced Thrombocytopenia and Thrombosis

Current Controversies in Lupus Anticoagulant Detection

Open access
Moore, Gary·2016·Antibodies

Abstract

Antiphospholipid syndrome is an autoimmune, acquired thrombophilia diagnosed when vascular thrombosis or pregnancy morbidity are accompanied by persistent antiphospholipid antibodies. Lupus anticoagulants (LA) are one of the criteria antibodies but calibration plasmas are unavailable and they are detected by inference based on antibody behaviour in a medley of coagulation-based assays. Elevated screening tests suggest the presence of a LA, which is confirmed with mixing tests to evidence inhibition and confirmatory tests to demonstrate phospholipid-dependence. At least two screening tests of different principle must be used to account for antibody heterogeneity and controversy exists on whether assays, in addition to dilute Russell's viper venom time and activated partial thromboplastin time, should be employed. A variety of approaches to raw data manipulation and interpretation attract debate, as does inclusion or exclusion of mixing studies in circumstances where the presence of a LA is already evident from other results. Therapeutic anticoagulation compromises coagulation-based assays but careful data interpretation and use of alternative reagents can detect or exclude LA in specific circumstances, and this aspect of LA detection continues to evolve. This review focuses on the main areas of debate in LA detection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antib5040022

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is currently no established gold standard assay or reference plasma for LA detection.

    “As a result, there are currently no established gold standard assays or reference plasmas for LA detection [[6], [7], [8], [9], [10]].”
  • Technical and practical issues, including test algorithms, interpretation parameters, cutoff values, and methods of interpretation, are problematic in many laboratories.

    “Technical and practical issues, including test algorithms, interpretation parameters, cutoff values, and methods of interpretation, are problematic in many laboratories [6,8,9,21].”
  • In theory, coagulation factors contained in PNP will correct the prolongation of the screening test if affected by a deficiency of one or more factors; if an inhibitor is present, the clotting time will remain prolonged.

    “In theory, the coagulation factors contained in PNP will correct the prolongation of the screening test, restoring a clotting time that falls in the range of normality, if affected by a deficiency of one (or more) factors; if an inhibitor is present, the clotting time will remain prolonged [46,47].”

    From Lupus Anticoagulant Detection under the Magnifying Glass (2023) · cites this paper as [47]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 101 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Moore, G.
Affiliations
St Thomas' Hospital (GB)
Corresponding author
Moore, Gary
Venue
Antibodies
Publisher
MDPI AG
Published
2016-12-02
Volume
5
Issue
4
Pages
22
ISSN
2073-4468 (ISSN-L)
OpenAlex
W2558208612
Cited by
36
References
101
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 3
FWCI
0.48
Type
journal article
Language
en
Open access
Locations
  • Antibodies (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Surgery › Heparin-Induced Thrombocytopenia and Thrombosis
Keywords
lupus anticoagulant, antiphospholipid syndrome, antiphospholipid antibodies, acquired thrombophilia, coagulation tests, dilute Russell's viper venom time, activated partial thromboplastin time, mixing studies, screening test, therapeutic anticoagulation, assay interpretation, antibody heterogeneity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review